Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Axcentua Pharmaceuticals AB
DescriptionMultitargeted anticancer compound with chemosensitizing and chemopreventative effects
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPancreatic cancer
Indication DetailsTreat advanced pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today